OCGN
$0.32
Ocugen
$.01
1.59%
OCGN
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.02)
Revenue:  $0.00 Mil
Friday
Nov 13
7:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when OCGN reports earnings?
Beat
Meet
Miss

Where is OCGN's stock price going from here?
Up
Flat
Down
Stock chart of OCGN
Analysts
Summary of analysts' recommendations for OCGN
Score
Grade
Pivots
Resistance
$0.34
$0.33
$0.33

$0.32

Support
$0.31
$0.30
$0.30
Tweet
Growth
Description
Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly known as Histogenics Cp, is based in Malvern, Pennsylvania.